Description
Saypha® Filler is a cross-linked hyaluronic acid dermal filler supplied as a sterile 1 mL prefilled syringe for professional aesthetic use. Licensed clinics, med spas, and healthcare professionals can order Saypha Filler for treatment-room workflows that require a cohesive, moldable HA gel. The 23 mg/ml hyaluronic acid concentration supports controlled placement for soft-tissue contouring and fine-line correction when used by qualified injectors.
Med Wholesale Supplies serves licensed clinic accounts with brand-name medical products sourced through vetted distributors and verified supply channels. Saypha® Filler is intended for trained professional administration, with clinic documentation, lot tracking, and protocol alignment handled according to your practice standards.
Saypha® Filler Price and Clinic Ordering
Clinics can sign in to view current Saypha Filler price information, available allocation, and account-specific purchasing terms. Pricing may vary by order quantity, contract arrangement, and inventory planning needs, so practices should review the current checkout view before scheduling cases around a specific lot or presentation.
This presentation is supplied as one 1 mL prefilled syringe containing cross-linked hyaluronic acid at 23 mg/ml. The ready-to-inject format helps reduce setup variability, supports efficient room turnover, and gives purchasing teams a simple unit for stock control. Product identifier SKU 89327 may be used for internal receiving, inventory records, and reorder coordination.
Orders are available to licensed buyers with verified professional accounts. Your team can coordinate Saypha® Filler with other aesthetic injectables and procedure supplies, including temperature-controlled handling when required and tracked US delivery. Use the product label and manufacturer documentation for lot number, expiry date, sterility, and any handling instructions that apply to the received pack.
What Saypha® Filler Is and How It Works
Saypha® Filler is part of the Croma dermal filler family. It is a cross-linked hyaluronic acid gel designed for injection into appropriate dermal or immediate subdermal planes by qualified providers. Hyaluronic acid is a naturally occurring water-binding molecule; in dermal fillers, cross-linking helps create a temporary gel matrix that can support shape, smoothness, and contour.
The product’s cohesive-elastic behavior allows controlled extrusion through standard aesthetic injection techniques selected by the provider. After placement, the gel can be shaped during the session according to tissue response, injection plane, and treatment objective. For broader portfolio planning, clinics can browse the Saypha brand range to view related presentations from the same family.
Why it matters: A predictable gel profile helps injectors plan technique, volume distribution, and follow-up timing across routine aesthetic indications.
Professional Applications and Treatment-Room Fit
Clinics use this preparation for refined facial contour work where a pliable hyaluronic acid gel is preferred. Common professional applications include lip contour refinement, perioral lines, nasolabial folds, marionette areas, and small-volume support in selected midface contours. Final product choice, injection depth, and technique should match the provider’s training, consent materials, and patient assessment.
Saypha® Filler can be useful when the goal is soft-tissue augmentation without moving directly to a higher-viscosity volumizing gel. It may fit protocols that call for controlled molding, smooth extrusion, and a familiar 1 mL syringe format. For additional clinic-facing context on this line, see the Saypha filler clinic overview.
Search interest often centers on whether Saypha Filler is “good” or how it compares with other HA products. For professional purchasing, the better question is whether the gel’s rheology, intended placement, syringe format, and documentation fit your injector’s protocol. No single filler is best for every indication, tissue type, or aesthetic plan.
Key Features for Clinic Evaluation
- Cross-linked hyaluronic acid gel for temporary soft-tissue support.
- 23 mg/ml HA concentration for consistent professional handling.
- Sterile 1 mL prefilled syringe for single-patient use.
- Cohesive, moldable texture for controlled placement and shaping.
- Smooth extrusion profile under standard injection techniques.
- Labeling supports lot, expiry, receiving, and treatment-record documentation.
- Suitable for clinics that maintain HA fillers across multiple facial indications.
- SKU 89327 supports purchasing and inventory control.
These features make the product straightforward for practices that already stock hyaluronic acid fillers. The concentration, syringe size, and sterile presentation are practical details for inventory rotation, case planning, and staff preparation before treatment sessions.
Composition, Pack Details, and Documentation
| Attribute | Clinic detail |
|---|---|
| Product | Saypha® Filler |
| Active ingredient | Cross-linked hyaluronic acid |
| Concentration | 23 mg/ml |
| Format | Sterile prefilled syringe |
| Pack configuration | 1 syringe of 1 mL |
| Use format | Single-use professional presentation |
| Inventory identifier | SKU 89327 |
The sterile syringe presentation supports consistent setup and helps staff maintain clear procedure-room workflows. Clinics should keep the manufacturer’s insert and outer packaging with receiving records until lot, expiry, and traceability details are captured according to the practice’s policies.
Excipients and complete composition details should be verified against the manufacturer documentation included with the pack. Do not rely on secondary summaries when updating consent forms, training files, or internal standard operating procedures.
Safety, Contraindications, and Professional Precautions
Dermal filler treatment requires appropriate patient selection, informed consent, aseptic technique, and readiness to manage adverse events. Hyaluronic acid fillers may be associated with injection-site swelling, bruising, tenderness, erythema, nodules, asymmetry, infection, hypersensitivity reactions, or vascular complications. Serious vascular events are uncommon but require prompt recognition and management by trained professionals.
Clinics should assess contraindications and precautions before treatment, including relevant allergy history, active infection or inflammation at the treatment site, prior filler history, anticoagulant or antiplatelet use, autoimmune or inflammatory conditions, pregnancy or breastfeeding status when applicable to clinic policy, and any history that could affect procedural risk. Treatment plans should also consider previous aesthetic procedures and the timing of lasers, energy-based devices, peels, threads, or surgery.
Use this product only within the scope of the injector’s training and the manufacturer’s instructions. Keep emergency protocols, appropriate supplies, and escalation pathways available for managing complications. For visual assessment and follow-up planning, the article on assessing dermal filler results can support clinic discussions about documentation and realistic review intervals.
Storage, Handling, and Inventory Planning
Store and handle Saypha® Filler according to the manufacturer’s instructions on the carton, syringe labeling, and package insert. Receiving staff should record lot number, expiry date, quantity received, and any shipping or storage conditions relevant to the product. Maintaining complete records supports traceability and helps clinics respond efficiently to recalls, audits, or internal quality checks.
Before each session, staff should verify that the sterile package is intact, the syringe matches the intended product, and the expiry date is acceptable for use. Do not use a syringe if packaging integrity is compromised or if product appearance raises concern under your practice protocol. Single-use sterile presentations should not be resterilized or shared between patients.
Quick tip: Separate filler inventory by gel family and viscosity profile so injectors can quickly select the intended syringe during room setup.
How It Compares with Other Saypha Options
Saypha® Filler is often evaluated alongside adjacent products in the same family. The right choice depends on tissue depth, desired lift, injection technique, and whether the injector wants a lidocaine-containing presentation. A practice that treats multiple facial zones may stock more than one gel profile to support consistent planning across fine lines, lips, folds, and deeper contour work.
For clinicians who prefer an anesthetic-containing format in a similar product class, consider Saypha® Filler with Lidocaine. For deeper or more structural augmentation, Saypha® Volume may be assessed as a higher-viscosity choice within the family. Practices that specifically require a lidocaine-containing volumizing presentation can also evaluate Saypha® Volume with Lidocaine.
Some clinics also plan skin-quality protocols separately from contouring protocols. In that context, Saypha® Rich may be reviewed for practices building a broader Croma Saypha assortment. For education on matching gel categories to clinical objectives, see the dermal filler selection guide.
Saypha Filler, Lidocaine, and Volume Decisions
The keyword “Saypha Filler Lidocaine” usually refers to a related presentation rather than this specific non-lidocaine item. Lidocaine-containing fillers may reduce injection discomfort for some patients, but they also require the provider to consider lidocaine-related precautions, allergy history, and practice protocols. Clinics should ensure ordering staff select the intended syringe before case scheduling.
“Saypha Volume,” “Saypha Volume Plus,” and similar searches point to products designed for different rheologic needs. A volume-oriented gel may be selected when the treatment plan requires more structural support, while a softer filler may suit finer contouring or areas where pliability is preferred. Product selection should remain indication-specific rather than brand-family driven alone.
For broader purchasing programs, the wholesale dermal filler planning article can help clinic teams think through assortment depth, treatment categories, and reorder timing without substituting for injector judgment.
Clinical Expectations and Result Review
Hyaluronic acid fillers provide temporary volume and contour support. The visible result depends on injection technique, product volume used, tissue characteristics, facial movement, hydration, metabolism, and aftercare. Clinics should avoid promising a fixed duration for every patient, because persistence varies by treatment area and individual response.
Follow-up visits allow providers to assess symmetry, integration, swelling resolution, and whether additional treatment is appropriate. Standardized photography, clear charting, and lot-level product records help make these reviews more useful. Patient-facing discussions should include expected swelling or bruising, activities to avoid under the clinic’s protocol, and symptoms that require urgent contact.
When combining HA filler with threads, energy-based devices, or other aesthetic treatments, staging matters. Practices should document the sequence, rationale, and follow-up plan so that each intervention can be assessed independently and safely.
Comparable Products and Assortment Planning
Comparable dermal fillers are not interchangeable solely because they contain hyaluronic acid. Gel firmness, cohesivity, cross-linking, concentration, extrusion behavior, lidocaine inclusion, and intended tissue plane all affect how a product performs in trained hands. Purchasing teams should involve injectors when adding or substituting products.
If Saypha® Filler is being evaluated against brands such as Juvederm, Teosyal, or other HA families, focus on the treatment indication and the provider’s established technique. SERP comparisons often ask which brand is “better,” but clinical selection is more specific: the better product is the one that fits the tissue, depth, desired correction, risk profile, and practitioner experience.
Clinics building a broader aesthetic category can review current thinking in advancements in dermal fillers. Use educational content for background only; ordering decisions should remain tied to manufacturer instructions, professional training, and patient-specific assessment.
Authoritative Sources
- Croma Saypha HA filler information — manufacturer information for the Saypha filler family.
- Croma Pharma official website — manufacturer and product-family background.
This content is for informational purposes only and is not a substitute for professional medical advice.
Frequently Asked Questions
Who can order Saypha® Filler from Med Wholesale Supplies?
Saypha® Filler is intended for licensed clinics, med spas, and healthcare professionals with verified professional accounts. Ordering requirements may include clinic documentation and account review before pricing and allocation are shown.
What is included in the Saypha® Filler pack?
The supplied presentation is one sterile 1 mL prefilled syringe containing cross-linked hyaluronic acid at 23 mg/ml. Clinics should verify lot number, expiry date, and manufacturer documentation when receiving the product.
Does this Saypha® Filler contain lidocaine?
This item is described as Saypha® Filler. Clinics that need a lidocaine-containing presentation should select the separate Saypha® Filler with Lidocaine product and confirm suitability against patient history and clinic protocols.
What areas do clinics commonly treat with Saypha® Filler?
Clinics commonly use this type of HA filler for lip contour refinement, perioral lines, nasolabial folds, marionette areas, and selected small-volume contour work. Treatment area, injection plane, and technique should be determined by a qualified provider.
How should clinics choose between Saypha® Filler and Saypha® Volume?
Saypha® Filler may suit softer contouring and refined placement, while Saypha® Volume is evaluated when a higher-viscosity gel is preferred for more structural support. The choice should reflect the treatment objective, tissue characteristics, and injector training.
What safety checks are important before using Saypha® Filler?
Clinics should assess medical history, allergies, active infection or inflammation, prior filler treatments, medications that affect bleeding, and any factors that may increase procedural risk. Emergency protocols and complication-management supplies should be available.
Can Saypha® Filler be combined with other aesthetic procedures?
It may be incorporated into broader aesthetic plans when staged appropriately by trained professionals. Clinics should document the sequence of fillers, threads, devices, or skin treatments so outcomes and adverse events can be assessed clearly.
Specifications
- Main Ingredient: Hyaluronic Acid
- Manufacturer: Croma Pharma
- Drug Class: Aesthetic Surgery Product
- Generic Name: Cross-Linked Hyaluronic Acid
- Package Contents: 1 mL x 1 Pre-Filled Syringe
- Storage Requirements: Room Temperature (2℃~25℃)
- Main Usage: Volume Filler, Fine Lines
About the Brand
Saypha
Here to help
Questions about ordering, delivery or products? You can email our team here or call now at 1-800-630-9757 and be connected with your dedicated Account Manager
Related Products
You save (%)
Juvéderm® SKINVIVE
You save (%)
You save (%)
You save (%)
Related Articles
After Care for Botox: Clinic Instructions and Safety Checks
In clinical practice, after care for botox is the set of written and verbal instructions…
Hyaluronidase in Aesthetic Practice: Safety and Workflow
Hyaluronidase is an enzyme that breaks down hyaluronic acid, a water-binding molecule found in skin,…
Jawline Filler in Aesthetic Care: Safety and Workflow
Jawline filler is a nonsurgical dermal filler approach used to refine lower-face contour, support the…
Dermal Fillers Before and After: Assessing Results
Dermal fillers before and after review should show whether an injectable treatment produced a visible,…
Elasticity of the Skin: Assessment and Treatment Planning
Elasticity of the skin is the skin’s ability to stretch, resist deformation, and return toward…
How Long Does Mirena Last? Duration, Labeling, and Workflow
Mirena is labeled to prevent pregnancy for up to 8 years, but its labeled duration…
Is Evenity a Bisphosphonate? Drug Class and Care Context
No. If you are asking is evenity a bisphosphonate, the short answer is no. Evenity…
What Causes Double Chin? Clinical Drivers and Red Flags
The main causes double chin presentations reflect are usually submental fat, inherited facial anatomy, chin…

